164 related articles for article (PubMed ID: 37208644)
21. The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells.
Chu YD; Yeh CT
Cells; 2020 Jul; 9(7):. PubMed ID: 32698392
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma.
Mirebeau-Prunier D; Guyétant S; Rodien P; Franc B; Baris O; Rohmer V; Reynier P; Tourmen Y; Malthièry Y; Savagner F
Eur J Endocrinol; 2004 Mar; 150(3):269-76. PubMed ID: 15012610
[TBL] [Abstract][Full Text] [Related]
23. Respiratory responses to hypercapnia and hypoxia in mice with genetic ablation of Kir5.1 (Kcnj16).
Trapp S; Tucker SJ; Gourine AV
Exp Physiol; 2011 Apr; 96(4):451-9. PubMed ID: 21239463
[TBL] [Abstract][Full Text] [Related]
24. Thyroid-stimulating hormone receptor affects metastasis and prognosis in papillary thyroid carcinoma.
Liu TR; Su X; Qiu WS; Chen WC; Men QQ; Zou L; Li ZQ; Fu XY; Yang AK
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3582-91. PubMed ID: 27649658
[TBL] [Abstract][Full Text] [Related]
25. CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer.
Li H; Zhou X; Wang G; Hua D; Li S; Xu T; Dong M; Cui X; Yang X; Wu Y; Cai M; Liao X; Zhang T; Yang Z; Du Y; Li X
J Clin Endocrinol Metab; 2022 Mar; 107(4):1110-1126. PubMed ID: 34751400
[TBL] [Abstract][Full Text] [Related]
26. Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression.
Chen S; Huang M; Hu X
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34212982
[TBL] [Abstract][Full Text] [Related]
27. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells.
Hoffmann S; Maschuw K; Hassan I; Wunderlich A; Lingelbach S; Ramaswamy A; Hofbauer LC; Zielke A
Endocrine; 2006 Aug; 30(1):129-38. PubMed ID: 17185801
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.
Hoffmann S; Hofbauer LC; Scharrenbach V; Wunderlich A; Hassan I; Lingelbach S; Zielke A
J Clin Endocrinol Metab; 2004 Dec; 89(12):6139-45. PubMed ID: 15579770
[TBL] [Abstract][Full Text] [Related]
29. TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer.
Su X; Lin LW; Weng JL; Chen SW; Yang XH; Zhou DL; Long YK; Shao Q; Ye ZL; Peng JL; Deng L; He CY; Yang AK
Cancer Biomark; 2019; 26(4):461-470. PubMed ID: 31658048
[TBL] [Abstract][Full Text] [Related]
30. TSH signalling and cancer.
García-Jiménez C; Santisteban P
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):654-71. PubMed ID: 17891229
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse.
Barzon L; Boscaro M; Pacenti M; Taccaliti A; Palù G
Int J Cancer; 2004 Jul; 110(6):914-20. PubMed ID: 15170676
[TBL] [Abstract][Full Text] [Related]
32. Elucidation of the molecular mechanisms of anaplastic thyroid carcinoma by integrated miRNA and mRNA analysis.
Liu G; Wu K; Sheng Y
Oncol Rep; 2016 Nov; 36(5):3005-3013. PubMed ID: 27599582
[TBL] [Abstract][Full Text] [Related]
33. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
[TBL] [Abstract][Full Text] [Related]
34. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics.
D'Agostino M; Sponziello M; Puppin C; Celano M; Maggisano V; Baldan F; Biffoni M; Bulotta S; Durante C; Filetti S; Damante G; Russo D
J Mol Endocrinol; 2014 Apr; 52(2):121-31. PubMed ID: 24353283
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning, characterization and expression of thyroid-stimulating hormone receptor in channel catfish.
Goto-Kazeto R; Kazeto Y; Trant JM
Gen Comp Endocrinol; 2009 May; 161(3):313-9. PubMed ID: 19523396
[TBL] [Abstract][Full Text] [Related]
36. Targeting the thyrotropin receptor in thyroid disease.
El-Kaissi S; Wall JR
Expert Opin Ther Targets; 2012 Jul; 16(7):719-27. PubMed ID: 22621289
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study.
Durai L; Ravindran S; Arvind K; Karunagaran D; Vijayalakshmi R
Mol Biol Rep; 2021 Nov; 48(11):7443-7456. PubMed ID: 34716862
[TBL] [Abstract][Full Text] [Related]
38. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma.
Qiu J; Zhang Y; Guo X; Zeng F; Zhao C; Qiu X; Wu X
Neoplasma; 2010; 57(4):360-4. PubMed ID: 20429628
[TBL] [Abstract][Full Text] [Related]
39. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing.
Xing M; Usadel H; Cohen Y; Tokumaru Y; Guo Z; Westra WB; Tong BC; Tallini G; Udelsman R; Califano JA; Ladenson PW; Sidransky D
Cancer Res; 2003 May; 63(9):2316-21. PubMed ID: 12727856
[TBL] [Abstract][Full Text] [Related]
40. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production.
Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M
Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]